ATLASTreace Medical Concepts (TMCI) earnings date: Nov 6, 2026
Treace Medical Concepts (TMCI) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026, before the open. Analysts expect EPS of -$0.25.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TMCI
| Last price | $4.27 (-3.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.3% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Treace Medical Concepts stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Treace Medical Concepts reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Treace Medical Concepts. You can switch it off at any time.
Alert me before TMCI reportsFree to start. Creating an account takes under a minute.
Notify me when Treace Medical Concepts reports
Track TMCI free Add Treace Medical Concepts to a free ATLAS watchlist and see its next report date in one place.
TMCI earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.25 |
| Last report | Aug 7, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +40.3% |
| Average move around a report | ±9.0% (last 5) |
| Sector | Healthcare · Medical Devices |
Treace Medical Concepts earnings history: last 5 reports
Treace Medical Concepts last reported on Aug 7, 2026: EPS of -$0.20 against an estimate of -$0.30 (+33.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.30 | -$0.20 | +33.3% | Beat | +6.6% |
| Jun 16, 2026 | $1.65 | $1.67 | +1.2% | In line | +2.3% |
| May 8, 2026 | -$0.31 | -$0.12 | +61.3% | Beat | +1.0% |
| Apr 8, 2026 | $0.35 | $0.57 | +62.9% | Beat | +14.2% |
| Feb 27, 2026 | -$0.14 | -$0.08 | +42.9% | Beat | -21.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TMCI
See the fair value, the probability range and the earnings history of Treace Medical Concepts on its ATLAS page.
Treace Medical Concepts (TMCI) stock analysisPlans from €3.99 a month.
Treace Medical Concepts earnings: frequently asked questions
When does Treace Medical Concepts (TMCI) report earnings?
Treace Medical Concepts is scheduled to report on Friday, November 6, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TMCI?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.25 per share (USD). Estimates can change before the report.
How often does TMCI beat earnings estimates?
Of its last 5 reports with a recorded result, Treace Medical Concepts beat the EPS estimate 4 times; the average surprise was +40.3%. Past results do not predict the next one.
How much does TMCI move around earnings?
Over its last 5 reports the stock moved an average of 9.0% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Treace Medical Concepts beat earnings estimates last quarter?
Treace Medical Concepts last reported on Aug 7, 2026: EPS of -$0.20 against an estimate of -$0.30 (+33.3% surprise), a beat.
How much does TMCI usually move in a day?
On a normal trading day the ATLAS model puts TMCI’s one-day range at about ±4.3%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer